Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Acute Myocardial Infarction Research, Chemotherapy-induced cardiotoxicity and mitigation, Cardiac Imaging and Diagnostics, and Heart Failure Treatment and Management.
Artificial intelligence for direct-to-physician reporting of ambulatory electrocardiography
Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer: A RADICAL-PC Analysis.
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative
Prediction Models for Heart Failure in the Community: A Systematic Review and Meta-Analysis
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative.
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
The Diagnosis and Management of Immune Checkpoint Inhibitor Cardiovascular Toxicity: Myocarditis and Beyond
Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients
Machine learning-based prediction of 1-year mortality for acute coronary syndrome<sup>✰</sup>.
Peripheral Arterial Disease in Patients With Acute Coronary Syndrome: Results From a Large Real-World Registry
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group
Distress among hospitalized patients with acute coronary syndrome
Illness perceptions of Israeli hospitalized patients with acute coronary syndrome
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology
Treatment specific toxicities: Hormones, antihormones, radiation therapy
Cardio-Oncology in Israel
Cardio-Oncology in Israel: Development and Future.
Primary cardiac sarcomas: A multi‐national retrospective review
Chronic exposure to traffic-related air pollution and cancer incidence among 10,000 patients undergoing percutaneous coronary interventions: A historical prospective study
Gender-Related Differences in Outcomes of Patients with Cardiac Resynchronization Therapy.
PubMed 2018cited by 3position: middle
Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus